Genetic causes of bronchiectasis: primary ciliary dyskinesia

Hilda N Morillas1, Maimoona Zariwala, Michael R Knowles

  • 1CF/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC 27599-7248, USA. hmorilla@med.unc.edu

Insights

Primary ciliary dyskinesia (PCD) is a genetic disorder affecting cilia and flagella, leading to various health issues. Genetic testing for DNAI1 and DNAH5 mutations aids in diagnosing PCD, with ongoing research expanding genetic screening for this condition.

Area of Science:

  • Genetics
  • Cell Biology
  • Medical Science

Background:

  • Primary ciliary dyskinesia (PCD) is a complex genetic disorder characterized by defects in motile cilia and flagella.
  • These defects impair mucociliary clearance, leading to recurrent respiratory infections, situs abnormalities, and infertility.
  • Genetic heterogeneity contributes to the diverse clinical presentations of PCD.

Purpose of the Study:

  • To summarize current understanding of PCD genetics.
  • To highlight the role of genetic testing in diagnosing PCD.
  • To underscore the ongoing discovery of novel genetic mutations and their associated phenotypes.

Main Methods:

  • Review of family-based linkage studies and candidate gene testing.
  • Description of a clinical genetic test targeting common mutations in DNAI1 and DNAH5.
  • Discussion of ongoing research into novel genetic associations and phenotypes.

Main Results:

  • Mutations in DNAI1 and DNAH5 are frequent causes of autosomal recessive PCD.
  • A targeted genetic test identifies mutations in approximately 25% of PCD patients.
  • New genetic mutations are continually being identified, expanding the understanding of PCD phenotypes.

Conclusions:

  • Genetic testing is crucial for diagnosing PCD, particularly for mutations in DNAI1 and DNAH5.
  • Continued genetic research is essential for identifying new disease-causing mutations and understanding PCD's full spectrum.
  • Broader genetic screening panels will improve PCD diagnosis and management.

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation